1-4 of 4
Annette Koerner
Close
Save search
Sort by
Journal Articles

Phase 2 Clinical Trial Results for Bitopertin, an Oral Glycine Transporter 1 Inhibitor, in Patients with Non-Transfusion Dependent Beta-Thalassemia

Free
Ali Taher, MD PhD, Vip Viprakasit, MD DPhil, Maria Domenica Cappellini, MD, Dominik Kraus, PhD, Patrick Cech, PhD, Volz Dietmar, PhD, Erica Winter, PharmD, Norman Alan Mazer, MD PhD, Stephane Nave, MD, Juergen Dukart, PhD, Franziska Schaedeli Stark, PhD, Annette Koerner, PhD, Omar Khwaja, MD PhD, Ricardo Hermosilla, DVM, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3635.
https://doi.org/10.1182/blood-2018-99-114776
Published: 2018
Journal Articles

Re-Assessing the Red Blood Cell Lifespan in Sickle Cell Anemia: Does Size Matter?

Free
Norman Alan Mazer, MD PhD, Tomas Tomka, BS, MS, Michael Winter, PhD DVM,, Annette Koerner, PhD, Samir K. Ballas, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4877.
https://doi.org/10.1182/blood-2018-99-110592
Published: 2018
Journal Articles

Quantifying the Pathophysiology of Beta-Thalassemia Using a Novel in-Silico Model of Red Blood Cell Production and Lifespan

Free
Norman Alan Mazer, MD PhD, Ricardo Hermosilla, PhD, Annette Koerner, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2227.
https://doi.org/10.1182/blood.V130.Suppl_1.2227.2227
Published: 2017
Journal Articles

A Selective ORAL GLYT1 Inhibitor, Improves Anemia and RED CELL Survival in a MOUSE MODEL of Beta-Thalassemia

Free
Carlo Brugnara, MD, Anja Harmeier, Lucia De Franceschi, MD, Alessandro Matte, Michael Winter, Annette Koerner, Omar Khwaja, Thomas Singer, Elisabetta Beneduce, Enrica Federti, Angela Siciliano
Journal: Blood
Blood (2016) 128 (22): 1284.
https://doi.org/10.1182/blood.V128.22.1284.1284
Published: 2016